chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Per hospital event reporting system " Pt was given MMR on 8/20/21. MMR had expired 8/13/21. Mother notified in office of expiration date. Contacted Merck manufacturer on 8/23/21 which stated no harm to pt and still effective. Merck to mail our office a letter for this pt. Mother contacted on 8/25/21 with this information. Lot # S025155"
This spontaneous report was received from healthcare professional refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. On 24-MAR-2016, the patient was vaccinated with a dose of improperly stored MMR II lot # L019989, expiration date: 01-JUN-2017, (dosage and route were not reported). Concomitant therapy was not reported. No adverse effects reported. Also was reported that the temperature excursion was 15 C, the time frame of the excursion was 4 hours, and that the vaccine had not had a previous temperature excursion. This is one of two reports received from the same reporter. Additional information has been requested.
I have had severe headache, neck pain, muscle weakness, fatigue, loss of memory, foggy brain, vision has been diminished and balance is off, and all symptoms are still current without any relief. I have been on 3 or 4 medications for migraine nothing has helped. I'm scheduled for MRI on December 10, 2021.
Fever, chills body/muscles aches, sweats, shakes, red/purple rash discoloration on both legs.
After taking Vivotif Live Attenuated Typhoid vaccine, I developed a rose-colored rash across my back.  This rash has recurred every time I get a viral illness or am stress or sleep-deprived.  I am a physician.
patient reported welts on face, forearms and wrist; headache vision change and swollen face; hard time swallowing medicine; patient was told to call md and take benedryl
several pt that recvd Engerix-B as their 2nd dose c/o sx they did not exp w/1st dose such as burning @ site of inject & down arm;
Developed night sweats, fatigue, myalgias,  lightheaded feeling 2 weeks after vaccine.
who presents to the emergency department with SOB and wheezing x 1 week. SOB at rest, worse with exertion like walking up a flight of stairs or walking to/from her car when at work. Using Albuterol MDI with some relief, last used at 1645. Yesterday pulse ox 89%, this morning 86%, before coming here 89%. +dry cough. No fever, temp has been 99 past few days. No chest pain, but chest feels tight when coughing and wheezing. Today HR was 120s before using Albuterol.
high fever above 101 degrees for 8 hours headache for 12 hours body chills for 6 hours sore throat
This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a patient who received BEXSERO for prophylaxis. On an unknown date, the patient received BEXSERO at an unknown dose. On an unknown date, unknown after receiving BEXSERO, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was unknown. It was unknown if the reporter considered the pain in arm to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. It was reported that the patient complained about sore arm.
Patient received flu vaccination on afternoon of 10/14/05.  She stated the rash started a couple of hours after the shot was given.  The rash consists of welts on various parts of her body that she says itches.  She denied having difficulty breathing or other signs or symptoms.  She showed the rash to me, her school nurse, on Monday morning around 10:00 AM.
No further information provided. No additional adverse events reported; Caller reports that a patient was administered an expired ROTATEQ today; This spontaneous report was received from a medical assistant and refers to a patient of unspecified age and gender. The patient's pertinent medical history, concomitant medications, past drug reactions or allergies were not reported.  On 25-JAN-2022, the patient was vaccinated with one (1) dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) oral liquid (concentration, vaccination scheme frequency, route of administration, and anatomical site of application were not reported; lot number 1742457 that was verified to be a valid lot number with an expiration date reported as 16-JAN-2022, but upon internal validation established as 06-JAN-2022) (expired product administered) as prophylaxis.  Additionally, it was reported that the dose was properly stored through the time of administration. No additional adverse events were reported (no adverse event).
got the Shingles shot and a short time later had shingles/ Suspected vaccination failure; shingles; was miserable; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles and feeling miserable. On an unknown date, the outcome of the vaccination failure and shingles were unknown and the outcome of the feeling miserable was recovered/resolved.   It was unknown if the reporter considered the vaccination failure, shingles and feeling miserable to be related to Shingles vaccine.  Additional details were reported as follows: This case was reported by patient's parent. The age at vaccination was not reported. The patient received the Shingles shot and a short time later had shingles. The patient was miserable for two or three months. This case was considered to be a suspected vaccination failure case, as the details regarding being full vaccination schedule, laboratory confirmation for shingles and exact time to onset were unknown.
Approximately 24 hours post vax, pt developed hives (awoke following morning with hives). Saw pediatrician who dxed hives and started Benadryl. Pt better after 1st dose.
Fever, chills, upset stomach, headache, back ache - all symptoms resolved within 24 hours.
adolescent received Havrix 1440; adolescent received Havrix 1440; received expired dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 16-year-old female patient who received HAV (Havrix 1440) (batch number KM72C, expiry date 18th June 2022) for prophylaxis.   On 26th July 2022, the patient received the 1st dose of Havrix 1440 1 ml. On 26th July 2022, unknown after receiving Havrix 1440, the patient experienced overdose, adult product administered to child and expired vaccine used. On an unknown date, the outcome of the overdose, adult product administered to child and expired vaccine used were unknown.   Additional Information: GSK receipt date: 27-Jul-2022 Reporter's comment: A pharmacy intern reported that an adolescent patient received an expired Havrix 1440 dose one day before the reporting the day. The reporter specifically stated it was Havrix 1440 but did not confirm if it was a PFS or SDV. The reporter consented to follow-up via email. Additional supportive information: An adolescent patient received an expired dose of Havrix 1440, which led to  overdose, adult product administered to child and expired vaccine used.
Palpitations, racing heart rate, supraventricular tachycardia. Treated with adenosine IV, Benadryl, Pepcid, dexamethasone.
I received my 2nd booster shot on 04/22/2022 and on the same day I experienced that my heart beat was really fast, my blood pressure was very high, that I almost called 911 and PVC wasn't normal. My blood pressure stayed for 22 weeks. My heart rate was high for 3 weeks and my heart rate is 55-57 which is normal and it was 70-80. On May 13/2022, it finally settled down. I called my doctor I told her that I was taking extra on my blood pressure med and she said it was ok to do that and it stated coming down. At night, my PVC was high so I was taking vallum to lowered it down. I did EKG before I got my booster shot and it was ok but after the vaccine everything went out.
AROUND 12:00 AM PT STARTED TO EXPERIENCE PAIN AND SWELLING OF WHOLE UPPER LEFT ARM - THE ARM IS WARM TO TOUCH AS WELL. PATIENT IS UNABLE TO MOVE ARM COMFORTABLY
Developed swelling, redness, warmth, pain and intense itchiness at injection site.  Mostly subsided by time patient reported event, with residual redness, pain, skin peeling on day event was reported.
No adverse event; Vaccine administered after beyond use date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date) and NO ADVERSE EVENT (No adverse event) in a 2-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AR9236B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 10-Nov-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date).    No concomitant medication information was reported. The vaccine received date reported as 13-Sep-2022 and beyond use date was reported as 13-Oct-2022. No treatment information was provided.
feeling Sick; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: feeling Sick). The outcome of the sickness was not reported.   The reporter considered the sickness to be related to Shingles vaccine.     The company considered the sickness to be related to Shingles vaccine.   Additional Information: GSK receipt date: 21-JUL-2023 This case was reported by a consumer via interactive digital media. The patient also got very sick, those crap vaccines affected him/her greatly.
On 10/8/10 I received a flu shot in my L deltoid. When the shot was given, I experienced intense pain at the site of injection. My arm was red & sore for 2-3 days. The redness & pain at the inj. site is gone, but I am now having worsening pain & stiffness in my shoulder, neck & back on the left side.
Vaccine coordinator is reporting the administration of improperly stored vaccines to unknown patients after the temperature excursion on 20JAN2022.; No adverse event; This spontaneous report was received from a vaccine coordinator and refers to a patient of unknown age and gender  The patient's pertinent medical history, drug reactions or allergies, and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin - rHA) (PROQUAD) subcutaneous injection, lot #U017138, expiration date: 28-NOV-2022, administered for prophylaxis (strength, and route of administration were not provided) that was improperly stored and on 20-JAN-2022 had a temperature excursion in -14C during 7 hours.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2205USA004997: US-009507513-2205USA005067:02167746
This case was reported by a consumer via call center representative and described the occurrence of sickness in a 66-year-old female patient who received SHINGRIX for prophylaxis. On 13th August 2018, the patient received the 1st dose of SHINGRIX. On 13th August 2018, less than a day after receiving SHINGRIX, the patient experienced sickness, pain in arm, headache, fever, chills and fear of death. On an unknown date, the outcome of the sickness, pain in arm, headache, fever and chills were recovering/resolving and the outcome of the fear of death was unknown. It was unknown if the reporter considered the sickness, pain in arm, headache, fever, chills and fear of death to be related to SHINGRIX. Additional details were provided as follows: The caller was calling on behalf of patient who was a female friend that stays with him. The caller stated that she was taking care of someone. The patient received 1st dose of SHINGRIX in an unknown arm. On the day of vaccination at evening, the patient felt sick, fever, chills and headache along with arm soreness. The patient stated that she was doing better on the day of reporting, but she felt like she was dying last night. It was recommended that she would seek assistance from healthcare professional to report the events and any necessary treatment recommendations. The healthcare professional not asked, as this was consumer reporting on behalf of a consumer friend.
Patient contracted COVID 19 and subsequently expired from respiratory distress, following completion of the serious of two vaccination shots.  She received her Moderna vaccinations on 1/7/21 and 2/4/21. I do not have access to the lot # info- would have to contact vaccination site to obtain
Myalgia, Arthralgia, Fever & UrticariaPruritus Narrative:
On Friday 4-9-10, patient noted neck stiffness and swollen lymph node below right earlobe. No fever or chills, but slight neck stiffness only. On 4-21-10, she presented with only the swollen lymph node below her right ear lobe.
macular papular rash p/72 hrs; treatment w/Calamine, aveno lotion, APAP & DPH; dizziness & visual disturbance ;
My symptoms started on February 05, 2022 I woke up & I had an electric shock feeling through my arm it also went through the 3rd branch of my face (right side) the pain traveled from the right to the left pain level would be on a scale of 20. I was hospitalized on February 15, 2022 I was released on February 16, 2022 and was diagnosed with Trigeminal Neuralgia. I was prescribed carbamazepine for my symptoms and I also take LYRICA as well.
Next day upper arm was swollen, erythema medially, warm to touch, pt felt "warm". Improved today, mild swelling, erythema.
Had a severe reaction to shot. Drs thought I was having a reaction to Atorvastatin so took me off of it as well as Gabapentin, Calcium, Vit D, I was given 2 rounds of steroids for 10 days each & rash didn't clear up. Gave me 21 days of steroids & after I was off of for 1 week It came back severly all over my body. The nursepractitioner finally sent me to see Dr & she immediately said I had an internal reaction going on She asked what I had done differently & when I looked back at my calender I saw I had a Shingrix shot & she thought that was my problem. She put me on Mycophenolate Mofetil 500mg tab 2xs daily & Hydroxyzine Hcl 50mg 3xs daily for the itchiness. She said my T-cells have been aggravated & it would take awhile for them to calm down. My head still itches sometimes. My skin seems to be doing better. If I get real hot I notice that the sub keratosis that I have all over will itch. I am scheduled to see Dr. on Nov 17th fo re-evaluate me. I had a severe rash all over my body & head & with uncontrollable itching. My pharmacist indicated I was probably allergic to the adjuvant that was added to the Shingrix shot. They also had me use Triamcinolone Acetonide Cream 0.1% to help relieve skin itching.
Per patient, next day after receiving Covid shot, she felt about 2" circular raised red area below injection site.  It's fading, still there, but no soreness.
No Additional AE/PQC; HCP called in to inform patient received expired dose of VAQTA.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, or medical history provided.  On 28-MAR-2023, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided) intramuscular injection, 1ml/x1, lot #U036184, expiration date: 02-MAR-2023, administered for prophylaxis (anatomical location and route of administration were not provided) (expired product administered). No additional adverse event (AE) reported.
severe allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of ALLERGY TO VACCINE (severe allergic reaction) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043a21a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced ALLERGY TO VACCINE (severe allergic reaction). At the time of the report, ALLERGY TO VACCINE (severe allergic reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
2/16/21 - Vaccine 1 Raised red rash on arm for 3 weeks, diarrhea with gastro pain for 1 month, rash on back for 2 weeks 3/16/21 - Vaccine 2 Raised red rash on arm smaller but only 2 weeks Early August noticed pea sized lumps under skin on abdomen multiplying quickly.  Went to ER the end of August with major abdominal pain (thought it was appendix) no findings. Asked about lumps, they werent sure. Saw a gastro doctor a week later, he said it was just normal fat. I saw my Dermo on 9/1 & 11/19 and she stated that it could be Dercum's Disease. Since November they have spread to my left arm and I now have even more on my abdomen, easily close to 100. Two near my ribs are occasionally painful and Dermo offered to refer me to a surgeon to remove them. I was fairly healthy before the vaccine and am concerned that it may have triggered some type of inflammatory/auto-immune response in my body.
expired Bexsero vaccine administered to a patient; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 18-year-old male patient who received Men B NVS (Bexsero) (batch number ABXB39AB, expiry date 31st July 2022) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 8th August 2022, the patient received Bexsero (intramuscular) .5 ml and Bexsero Pre-Filled Syringe Device. On 8th August 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 09-AUG-2022 Reporter's Comments: The health care professional reported that an expired Bexsero vaccine was administered to the patient. Patient received the expired Bexsero in the left arm. The reporter consented to follow up. Additional Supportive Information: The patient was administered with expired Bexsero vaccine which led to expired vaccine used.
Patient developed horrible COVID like symptoms for 8 days after receiving the first dose; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Patient developed horrible COVID like symptoms for 8 days after receiving the first dose) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (She had the COVID-19 virus in end of January 2021) in January 2021.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced SUSPECTED COVID-19 (Patient developed horrible COVID like symptoms for 8 days after receiving the first dose). At the time of the report, SUSPECTED COVID-19 (Patient developed horrible COVID like symptoms for 8 days after receiving the first dose) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In January 2021, SARS-CoV-2 test: positive (Positive) Positive. Had the COVID-19 virus in end of January 2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant product use was reported. No treatment information was provided.  The patient 22 hours after receiving their first dose of Moderna vaccine developed horrible COVID like symptoms for 8 days. The patient reported that they had the COVID-19 virus in end of January 2021, and they experienced similar side effects after vaccination.
Pt was administered vaccine on 10/5/22. Pharmacy reported vaccine recall for being shortdated to 9/30/22 on 10/12/22. Mother reported no significant adverse reaction except for a sore arm. She will wait for upcoming pediatric booster.
This spontaneous report as received from a certified medical assistant refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history and concurrent conditions was provided. On unknown dates, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB lot # M010212, expiration date: 21-JAN-2019, (dose, dose number, route of administration and injection site were not provided). There were no concomitant medications reported. It was stated that the vaccine underwent temperature excursion of 0.4 degrees Celsius for 4 days 5 hours and 45 minutes and 9.2 degrees Celsius for 23 hours and 30 minutes, respectively. The temperature excursion was captured using data logger. No previous temperature excursions were reported. No adverse effects were reported. At the time of reporting, the temperature was back in range. Additional information has been requested.
deep tissue pain still at the site of the injection; pain radiates up to her shoulder; radiating pain; This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 88-year-old female patient who received Herpes zoster (Shingrix) (batch number 2N9CT, expiry date 18th March 2022) for prophylaxis.   On 1st February 2020, the patient received Shingrix (intramuscular) .5 ml. On an unknown date, less than 2 months after receiving Shingrix, the patient experienced pain in arm, shoulder pain and radiating pain. On an unknown date, the outcome of the pain in arm and radiating pain were unknown and the outcome of the shoulder pain was not recovered/not resolved.   It was unknown if the reporter considered the pain in arm, shoulder pain and radiating pain to be related to Shingrix.  Additional details were reported as follows: The patient received Shingrix vaccine and had deep tissue pain still at the site of the injection. The pain radiates up to her shoulder a little bit.  It also radiates from the injection site down and up.  It bothers her when she sleeps.  It was not unbearable, but it wasn't the surface of the skin, it was deep pain.
This spontaneous case, initially received from a pharmacist on 20-Oct-2018, concerns a female patient of an unspecified age. The patient received unknown flu vaccine and experienced arm swelling. On an unspecified date, the patient was administered influenza vaccine [dose, route of administration, anatomical location, batch number, expiry date, trade name and manufacturer: not reported). On an unspecified date, after vaccination, the patient experienced swelling in the arm. On an unspecified date, 2 days after onset of the event (2 days after start as reported), the patient had recovered from the event. The reporter assessed the case as non-serious.